Skip to main content
. 2018 May 3;154(3):521–531. doi: 10.1016/j.chest.2018.03.059

Table 3.

Baseline Characteristics and Treatments in Patients From the Normally Perfused Group and the Poorly Perfused Group

Variable Normally Perfused
(n = 82)
Poorly Perfused
(n = 19)
P Value
Baseline characteristics
 Age, y 63.6 ± 13.9 62.5 ± 13.8 .765
 Male 42 (51.2%) 12 (63.2%) .374
 BAA, mm2 8.7 [6.9-11.3] 7.0 [5.8-9.6] .032
 NYHA functional class (I, II/III, IV), % 32.0/68.0 5.3/94.7 .018
 6MWD, m 404 ± 114 378 ± 174 .421
 Dlco, % 63.3 ± 13.7 55.9 ± 11.4 .037
Baseline hemodynamic variables
 Mean RAP, mm Hg 8.0 ± 3.6 8.7 ± 4.1 .458
 Systolic PAP, mm Hg 77.8 ± 17.5 80.6 ± 17.1 .543
 Diastolic PAP, mm Hg 24.4 ± 7.9 29.1 ± 6.9 .019
 Mean PAP, mm Hg 44.9± 10.3 48.6 ± 9.7 .161
 PAWP, mm Hg 9.4 ± 3.8 9.8 ± 2.8 .707
 DPG, mm Hg (diastolic PAP-PCWP) 15.0 ± 8.4 19.3 ± 6.9 .042
 Cardiac output, L/min 4.71 ± 1.26 4.34 ± 1.03 .246
 Cardiac index, L/min/m2 2.57 ± 0.52 2.34 ± 0.47 .083
 PVR, Wood unit 8.12 ± 3.20 9.03 ± 3.0 .271
 Svo2, % 62.4 ± 7.2
(n = 61)
57.9 ± 6.2
(n = 12)
.046
PH medical treatment at baseline
 No treatment/monotherapy/ double combination therapy/ triple combination therapy, % 48/25/23/4 37/16/42/5 .348

Data are presented as mean ± SD or median [interquartile range] unless otherwise indicated. See Table 1 legend for expansion of abbreviations.